Since PTSD is associated with glucocorticoid alterations including enhanced glucocorticoid sensitivity [5] and elevated corticotropin releasing factor (CRF) levels [6, 7], short-term administration of mifepristone may reverse some of the stress-related neurobiological changes associated with this disorder and restore homeostasis to this system. The gene discussed is CRH; the disease is post-traumatic stress disorder.